
The development of novel zzso agents in older patients presents both challenges and unique zzso zzso zzso due to zzso conditions and the use of multiple zzso medications may overshadow other age-related differences in zzso The increasing interest in oral agents may be especially problematic in older patients who have difficulty with zzso particularly if the oral agents are given in combination or according to complex zzso zzso chronic zzso conditions, and impaired organ reserve in the elderly can lead to zzso differences such as increased toxicity and, zzso reduced zzso zzso immune responsiveness is an important area zzso further zzso The development of novel agents to treat older patients with cancer cannot be successfully accomplished without increasing the proportion of elderly patients entered into clinical zzso Furthermore, data obtained from studies in older patients may provide valuable information zzso to the development of novel agents in younger patients and to a better understanding of cancer biology and treatment in zzso 

